IL1B and neoplasm: Inflammatory mediators—such as TNF‐α, IL‐1β, iNOS, and COX2—act as molecular accelerants of tumor initiation and progression by fostering genomic instability, promoting cellular proliferation, and suppressing tumor immune surveillance (Sgambato and Cittadini 2010).